|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.28 USD | +6.70% |
|
+28.96% | +100.62% |
| 07-30 | B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating | MT |
| 07-30 | Barrington Raises Price Target on Anika Therapeutics to $21 From $17, Keeps Outperform Rating | MT |
| Market Cap | 258M 224M 209M 192M 362M 24.63B 368M 2.46B 966M 12.26B 969M 948M 41.12B | P/E 2026 * |
-1,928x | P/E 2027 * | 41.5x |
|---|---|---|---|---|---|
| Enterprise Value | 258M 224M 209M 192M 362M 24.63B 368M 2.46B 966M 12.26B 969M 948M 41.12B | EV / Sales 2026 * |
2.11x | EV / Sales 2027 * | 2.01x |
| Free-Float |
79.74% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Anika Therapeutics, Inc.
| 1 day | +6.70% | ||
| 1 week | +28.96% | ||
| 1 month | +25.52% | ||
| 3 months | +29.83% | ||
| 6 months | +100.21% | ||
| Current year | +100.62% |
| 1 week | 15.02 |  | 19.29 |
| 1 month | 14.58 | | 19.29 |
| Current year | 9.01 | | 19.29 |
| 1 year | 7.92 | | 19.29 |
| 3 years | 7.87 | | 29.12 |
| 5 years | 7.87 | | 45.81 |
| 10 years | 7.87 | | 75.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Griffin
CEO | Chief Executive Officer | 40 | 2026-01-31 |
Dawn J. Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 2023-08-31 |
Mira Leiwant
CTO | Chief Tech/Sci/R&D Officer | - | 2019-10-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheryl Blanchard
CHM | Chairman | 61 | 2026-01-31 |
John Henneman
CHM | Chairman | 64 | 2024-02-23 |
Stephen Richard
BRD | Director/Board Member | 63 | 2020-09-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/1/26 | Other | Chief Executive Officer | 440,609 | 3.0553% | ||
| 6/20/25 | Free | Director | 14,164 | 0.0967% | ||
| 6/20/25 | Free | Director | 14,164 | 0.0967% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.70% | +28.96% | +123.15% | -13.89% | 258M | |
| +0.09% | +2.56% | -16.96% | -2.69% | 183B | |
| -0.37% | +2.62% | -4.42% | -0.08% | 109B | |
| -0.29% | +0.47% | +7.97% | +62.64% | 60.57B | |
| +2.37% | +2.16% | +39.83% | +55.40% | 51.8B | |
| +0.10% | +5.92% | -6.10% | -40.04% | 45.64B | |
| +0.41% | +1.37% | - | - | 33.22B | |
| +11.95% | +16.65% | +5.26% | -32.60% | 31.49B | |
| +0.40% | +3.89% | +42.51% | -7.99% | 24B | |
| -1.22% | +6.69% | +0.67% | +0.26% | 22.26B | |
| Average | +2.12% | +6.96% | +21.32% | +2.33% | 56.14B | |
| Weighted average by Cap. | +1.15% | +3.38% | -0.16% | +5.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 122M 106M 98.91M 90.81M 171M 11.67B 174M 1.17B 458M 5.81B 459M 449M 19.48B | 129M 112M 104M 95.5M 180M 12.27B 183M 1.23B 481M 6.11B 483M 472M 20.49B |
| Net income | -67.5K -58.68K -54.62K -50.14K -94.69K -6.44M -96.16K -644K -253K -3.21M -254K -248K -10.76M | 6.42M 5.58M 5.2M 4.77M 9.01M 613M 9.15M 61.26M 24.04M 305M 24.12M 23.59M 1.02B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$19.28 | +6.70% | 170,487 |
| 26-07-30 | US$18.07 | +11.75% | 114,432 |
| 26-07-29 | US$16.17 | +6.73% | 124,880 |
| 26-07-28 | US$15.15 | +0.87% | 52,172 |
| 26-07-27 | US$15.02 | +0.47% | 50,567 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANIK Stock
Select your edition
All financial news and data tailored to specific country editions
